The Genuair® inhaler: a novel, multidose dry powder inhaler.
about
Aclidinium bromide for the treatment of chronic obstructive pulmonary diseaseCombination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseDrug-targeting methodologies with applications: A reviewIs aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.Dry powder inhalers and the right things to remember: a concept review.Dry-powder inhalers in patients with persistent airflow limitation: usability and preference.The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.Recent advances in COPD disease management with fixed-dose long-acting combination therapies.Dry powder inhalers in COPD, lung inflammation and pulmonary infections.Inhalation drug delivery devices: technology update.Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.Devices for dry powder drug delivery to the lung.Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.Preference, satisfaction and errors with two dry powder inhalers in patients with COPD.Inhalation device options for the management of chronic obstructive pulmonary disease.Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.The use of a quartz crystal microbalance as an analytical tool to monitor particle/surface and particle/particle interactions under dry ambient and pressurized conditions: a study using common inhaler components.Genuair® Usability Test: Results of a National Public Survey of the Elderly.Genuair(®) in chronic obstructive pulmonary disease: a novel, user-friendly, multidose, dry-powder inhaler.The acoustic features of inhalation can be used to quantify aerosol delivery from a Diskus™ dry powder inhaler.Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD.Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
P2860
Q22306019-909B69BF-25B5-4798-A20A-EF6797DAE5DDQ27012625-B6590B1D-0BCA-476A-BB51-9B55E631434AQ28649786-A36ADD9D-1C86-4937-BF28-3F0941B76E6FQ30365242-1DFC6968-0011-4283-BDF2-65A3B0DAFEB7Q34336907-CA7CBD1F-A613-46B1-9C8D-44D87F33E32EQ35426748-FF52BC44-B494-46DB-B49C-45F59D80FC1FQ37232076-905936C7-53A2-4527-B90A-268555F90101Q38052955-F45A0144-4FA1-4044-A476-DAE2BD7B23AFQ38209841-7A43ABC9-C1AB-4B9A-98ED-7D16647E0DD2Q38267333-51E49DE0-FB8D-4AA2-B3F2-E38D23480BCDQ38364686-1D94C2F2-B304-412D-965C-80DAA06E45E0Q38371305-4ED2A453-9A8C-4799-86E9-BB3D11B04C21Q38474246-76639103-5676-4CC9-8ECF-6F84A7A15B59Q38586322-E8BE858E-B662-4329-8088-E62F4FE7B140Q42602587-8929801C-5BD5-45AB-8529-4A3EC5D0AA03Q47279539-A95CDD4D-B936-47A2-8BEE-DFB6C5F0E126Q47652466-06CB58C5-B4B9-496A-BB35-B4FD180FDC3DQ50026720-32C3A008-C48C-46F3-89D7-1D243A24C801Q51084885-A230DBDA-D0CC-488D-8CA6-611C5E0D296BQ51567216-E64B1B15-E765-4491-B4CD-91C44434BA5EQ51692765-1B8DA84C-D698-41EE-8DC3-14AA3DC6219FQ51721208-33DCFF23-ED05-474D-B976-7E43A67697AFQ55120067-E7E4E2E9-C3F5-4594-87C5-9EE3B857BA9CQ55301329-FE34FD05-30F3-4662-B11F-B28804148F40
P2860
The Genuair® inhaler: a novel, multidose dry powder inhaler.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@en
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@nl
type
label
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@en
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@nl
prefLabel
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@en
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@nl
P2860
P1476
The Genuair® inhaler: a novel, multidose dry powder inhaler.
@en
P2093
C Niederlaender
H Chrystyn
P2860
P304
P356
10.1111/J.1742-1241.2011.02832.X
P577
2012-03-01T00:00:00Z